| Journal Profile | |||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Journal Title | Lancet HIV | ||||||||||||||||||||||||||||
| Journal Title Abbreviations | LANCET HIV | ||||||||||||||||||||||||||||
| ISSN | 2352-3018 | ||||||||||||||||||||||||||||
| h-index | 34 | ||||||||||||||||||||||||||||
| CiteScore |
| ||||||||||||||||||||||||||||
| Self-Citation Ratio (2020-2021) | 4.50% | ||||||||||||||||||||||||||||
| 期刊简介 | Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. | ||||||||||||||||||||||||||||
| Official Website | http://www.journals.elsevier.com/the-lancet-hiv/ | ||||||||||||||||||||||||||||
| Online Manuscript Submission | https://www.editorialmanager.com/THELANCETHIV | ||||||||||||||||||||||||||||
| Open Access | No | ||||||||||||||||||||||||||||
| Publisher | 525 B STREET, STE 1900, SAN DIEGO, USA, CA, 92101-4495 | ||||||||||||||||||||||||||||
| Subject Area | IMMUNOLOGYINFECTIOUS DISEASES& | ||||||||||||||||||||||||||||
| Country/Area of Publication | ENGLAND | ||||||||||||||||||||||||||||
| Publication Frequency | |||||||||||||||||||||||||||||
| Year Publication Started | 0 | ||||||||||||||||||||||||||||
| Annual Article Volume | 64 | ||||||||||||||||||||||||||||
| Gold OA文章占比 | |||||||||||||||||||||||||||||
| OA期刊相关信息 | |||||||||||||||||||||||||||||
| WOS期刊SCI分区 | |||||||||||||||||||||||||||||
| Indexing (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||||||||||
| Link to PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2352-3018%5BISSN%5D | ||||||||||||||||||||||||||||
| Average Duration of Peer Review * | Authorized Data from Publisher: Data from Authors: | ||||||||||||||||||||||||||||
| Competitiveness * | Data from Authors: | ||||||||||||||||||||||||||||
| Useful Links |
| ||||||||||||||||||||||||||||
| *All review process metrics, such as acceptance rate and review speed, are limited to our user-submitted manuscripts. As such they may not reflect the journals' exact competitiveness or speed. | |||||||||||||||||||||||||||||
| |
| First Previous 1 Next Last (To Page | |
| Reviews on Lancet HIV: | Write a review |
| Author: 维尔娜菲茨杰拉德 Subject Area: Medicine Duration of Peer Review: 0.0 month(s) Result: Pending & Unknown Write a review |
Reviewed 2021-12-30 22:22:40 The discussion section is the core part of a SCI paper, as it can demonstrate the breadth and depth of the author's research. Therefore, there is no specific word limit for this section. The length of the discussion section varies from article to article and from author to author, ranging from a few thousand words to tens of thousands of words  (0) Thank | 维尔娜菲茨杰拉德  |
| Author: 维尔娜菲茨杰拉德 Subject Area: Medicine Duration of Peer Review: 0.0 month(s) Result: Pending & Unknown Write a review |
Reviewed 2021-12-30 12:58:15 The discussion section is the core part of a SCI paper, as it reflects the breadth and depth of the author's research. Therefore, there is no specific word limit for this section. Depending on the article and the author, the length of the discussion section can vary greatly, ranging from a few thousand words to tens of thousands of words (0) Thank | 维尔娜菲茨杰拉德 |
| Author: 北国博达 Subject Area: Medicine Duration of Peer Review: 0.0 month(s) Result: Pending & Unknown Write a review |
Reviewed 2021-12-28 22:06:53 How many words are generally recommended for a discussion? (0) Thank | 北国博达 |
| Author: 修然小公主 Subject Area: Medicine Duration of Peer Review: 0.0 month(s) Result: Pending & Unknown Write a review |
Reviewed 2021-12-27 18:29:17 Is the lengthy discussion showing the author's deep thoughts on the topic? Did the reviewers have a positive impression of the manuscript? (0) Thank | 修然小公主 |
| Author: 凌霄高洁 Subject Area: Medicine Duration of Peer Review: 0.0 month(s) Result: Pending & Unknown Write a review |
Reviewed 2017-07-16 16:29:30 8-10 points is already very good, as long as it is maintained at this level in the long term, it is an international first-class journal (0) Thank | 凌霄高洁 |
| Author: 北国梦菡 Subject Area: Medicine Duration of Peer Review: 0.0 month(s) Result: Pending & Unknown Write a review |
Reviewed 2016-06-14 23:19:19 Review Speed: 2.0 | Submission Acceptance Rate: 25.0 Experience Sharing: Over 8 points, instantly fabulous! (0) Thank | 北国梦菡 |
| Author: 神古苑博 Subject Area: Medicine Duration of Peer Review: 0.0 month(s) Result: Pending & Unknown Write a review |
Reviewed 2016-02-16 11:55:29 Review speed: 1.0 | Submission acceptance rate: 25.0 Experience sharing: A new journal under Lancet, entering SCI, should be good (0) Thank | 神古苑博 |
| First Previous 1 Next Last (To Page | |